Related Experiment Videos

p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine

R S Alpan1, A B Pardee

  • 1Division of Cell Growth and Regulation, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|July 1, 1996
PubMed

Insights

Mimosine, a cell cycle blocker, increases p21 levels and inhibits cyclin E activity, inducing a G1 phase arrest in breast cancer cells. This suggests mimosine can restore the G1 checkpoint via a p53-independent pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The p53 tumor suppressor regulates cell cycle control, particularly the G1 and G2 phases.
  • p21WAF1/CIP1/SDI1 (p21) is a key downstream effector of p53, inducing G1 arrest.
  • Mimosine is a known reversible inhibitor of late G1 phase progression.

Purpose of the Study:

  • To investigate the effects of mimosine on the cell cycle and p21 pathway in human breast cancer cells.
  • To determine if mimosine can restore a functional G1 checkpoint.

Main Methods:

  • Treatment of 21PT human breast cancer cells with mimosine.
  • Analysis of p21 mRNA and protein expression.
  • Assessment of cyclin E-associated kinase activity.
  • Cell cycle phase analysis.

Main Results:

  • Mimosine increased both p21 mRNA and protein levels.
  • Cyclin E-associated kinase activity was indirectly inhibited by mimosine.
  • Human breast cancer cells were blocked in the late G1 phase.
  • Mimosine induced a p53-independent p21 pathway.

Conclusions:

  • Mimosine can restore a G1 checkpoint in human breast cancer cells.
  • The mechanism of mimosine involves a p53-independent induction of p21.
  • Mimosine's complex mechanism may involve multiple cellular targets.

Related Concept Videos